Annual Report 2026 - Ajanta Pharma Ltd.BSE · annual report · 140 pages
VerifiedArchived copy Company dossier
Ajanta Pharma
NSE:AJANTPHARM · ISIN INE031B01049
- Close
- Unavailable Date unavailable
- Daily change
- N/A Exchange close
- Evidence state
- Building 0/0 checks
Ajanta Pharma
Business
Business evidence pack
Source documentsPrimary material for understanding Ajanta Pharma
Business-model synthesis will be generated from the company's annual reports, investor presentations and conference-call material. Until that layer is reconciled, IndiaTicker shows the source pack instead of company-specific claims.
Ajanta Pharma Ltd - 532331 - Reg. 34 (1) Annual Report.BSE · annual report · 140 pages
VerifiedArchived copy Annual Report 2025 - Ajanta Pharma Ltd.BSE · annual report · 138 pages
VerifiedArchived copy Shareholders meeting - Ajanta Pharma LimitedNSE · annual report · 137 pages
VerifiedArchived copy Updates - Ajanta Pharma LimitedNSE · annual report · 183 pages
VerifiedArchived copy Updates - Ajanta Pharma LimitedNSE · annual report · 183 pages
VerifiedArchived copy Updates - Ajanta Pharma LimitedNSE · annual report · 184 pages
VerifiedArchived copy Updates - Ajanta Pharma LimitedNSE · annual report · 184 pages
VerifiedArchived copy Financial Year 2012 from bseBSE · annual report · 83 pages
VerifiedArchived copy Financial Year 2020 from bseBSE · annual report · 209 pages
VerifiedArchived copy Financial Year 2025 from bseBSE · annual report · 138 pages
VerifiedArchived copy Financial Year 2022 from bseBSE · annual report · 209 pages
VerifiedArchived copy Financial Year 2015 from bseBSE · annual report · 141 pages
VerifiedArchived copy Financial Year 2017 from bseBSE · annual report · 187 pages
VerifiedArchived copy Financial Year 2024 from bseBSE · annual report · 137 pages
VerifiedArchived copy Financial Year 2019 from bseBSE · annual report · 199 pages
VerifiedArchived copy